TCA
AVDL

Troluce Capital Advisors’s Avadel Pharmaceuticals AVDL Stock Holding History

Troluce Capital Advisors’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-150,000
Closed -$2.11M – 51
2024
Q2 		$2.11M Buy
+150,000
New +$2.11M 0.21% 30